Agile Therapeutics - Stock Split History | AGRX

Stock split history for Agile Therapeutics since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Agile Therapeutics Annual Stock Splits
Agile Therapeutics Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.103B $0.000B
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $60.580B 11.04
Teva Pharmaceutical Industries (TEVA) Israel $11.194B 4.56
Bausch Health Cos (BHC) Canada $9.780B 6.45
Mylan (MYL) United States $8.965B 4.02
Dr Reddy's Laboratories (RDY) India $6.679B 17.52
ASPEN PHARMACR (APNHY) South Africa $3.707B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.145B 11.08
Amphastar Pharmaceuticals (AMPH) United States $0.847B 44.00
Homology Medicines (FIXX) United States $0.632B 0.00
Voyager Therapeutics (VYGR) United States $0.531B 0.00
Akorn (AKRX) United States $0.484B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.449B 0.00
Assembly Biosciences (ASMB) United States $0.363B 0.00
CymaBay Therapeutics (CBAY) United States $0.359B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.260B 0.35
Zynerba Pharmaceuticals (ZYNE) United States $0.156B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.152B 0.00
Sol-Gel Technologies (SLGL) Israel $0.151B 0.00
Teligent (TLGT) United States $0.034B 0.00
China Pharma Holdings (CPHI) China $0.010B 0.00